Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi

European Journal of Nuclear Medicine

Volumn 21, Issue 4, 1994, Pages 357-362

  Khalkhali, Iraj ^a   Mena, Ismael ^a   Diggles, Linda ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Breast imaging; Technetium 99m sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

BODY POSITION; BREAST CANCER; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SCINTIGRAPHY; SHORT SURVEY;

ADULT; BREAST NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MIDDLE AGE; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES;

EID: 0028353518     PISSN: 03406997     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/BF00947973     Document Type: Review

References (45)

1. Mammographic screening and mortality from breast cancer: the Malmo Mammographic Screening Trial
2. Mammographic features of 300 consecutive non-palpable breast cancers
3. Stereotactic breast biopsy with a biopsy gun
4. Positive predictive value of mammography
5. The mathematics of screening mammography
6. Screening for breast cancer
7. The epidemiology of mass breast cancer screening — a plea for a valid measure of benefit
8. Cost of screening for breast cancer
9. Principles of mass screening for breast cancer
10. A dissent from Dr. Schmidt's appraisal of evidence on breast cancer screening
11. Early detection of breast cancer in women
12. Occult breast cancer: prevalence and radiographic detectability
13. False-negative mammograms in patients with breast cancer
14. Observer variation in classification of mammographic parenchymal patterns
15. Audit procedures in the national breast screening study: mammography interpretation
16. Inter-observer variability in the interpretation of mammograms
17. Breast Cancer Detection Demonstration Project: five-year summary report
18. NMR relaxation and images of human breast tumors in vitro
19. Carcinoma of the breast: imaging by NMR
20. MR imaging of the breast with rotating delivery of excitation of resonance: clinical experience with pathological correlation
21. Fat-suppressed three-dimensional MR imaging of the breast
22. “Residual” mammary carcinoma following simulated partial mastectomy
23. Multicenttricity of nonpalpable breast cancer
24. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose
25. 18F]fluoro-D-glucose in liver metastases from colon carcinoma
26. 18F-fluorodeoxyglucose [letter]
27. Metabolic imaging of human extremity musculoskeletal tumors by PET
28. Recurrence of colorectal tumors: PET evaluation
29. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease
30. Thallium 201 chloride uptake in tumours, a possible implication in heart scintigraphy
31. Increased accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in osteosarcoma and its metastatic lymph nodes
32. SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylnitrile) technetium (I)
33. 201Tl chloride
34. Breast carcinomas detected by thallium-201 scintigraphy
35. Thallium scintigraphy in the evaluation of mass abnormalities of the breast
36. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs
37. Subcellular distribution and analysis of Tc-99m MIBI in isolated perfused rat hearts
38. Uptake of the cation hexakis (2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro
39. Technetium-99m MIBI and thallium-201 uptake in bronchial carcinoma [abstract]
40. In vitro uptake of Tc-99m texoboroxime in carcinoma cell lines and normal cell lines: comparison with Tc-99m sestamibi and thallium-201